לבטיראצטם טבע ® 1000 מ"ג

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

LEVETIRACETAM 1000 MG

Prieinama:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodas:

N03AX14

Vaisto forma:

TABLETS

Vartojimo būdas:

PER OS

Pagaminta:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Farmakoterapinė grupė:

LEVETIRACETAM

Terapinės indikacijos:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Leidimo data:

2009-09-01